Gladstone NOW: The Campaign Join Us on the Journey ✕
1291 - 1305 of 1393 Results Clear All
SAN FRANCISCO, CA—Gladstone President R. Sanders "Sandy" Williams, MD, will receive the ARCS Foundation’s 2012 Pacesetter Award next week for his lifelong dedication to furthering education and his extensive contributions to science and medicine.
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease)—a fatal disease for which there is no cure.
ALS
SAN FRANCISCO, CA—Using animal models, scientists at the Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)—a form of early-onset dementia that is similar to Alzheimer’s disease.
Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that, like embryonic stem cells, are capable of developing into any cell in the human body.
Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes—and revealing new clues as to what happens when this process goes awry.
Basic Science Weinberger Lab
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.
Bruneau Lab
SAN FRANCISCO, CA—New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention.
Grant Lab HIV/AIDS
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.
HIV/AIDS Weinberger Lab
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
Alzheimer’s Disease Epilepsy Mucke Lab
SAN FRANCISCO, CA—For a second year in a row, an annual survey from The Scientist magazine has named the Gladstone Institutes as the best place to work in academia.
SAN FRANCISCO, CA—The Gladstone Institutes has joined forces with Jesse Dylan’s award-winning film company to raise public awareness—through a series of short films—about unmet medical needs that Gladstone scientists and supporters are addressing
SAN FRANCISCO, CA—July 23, 2012—Warner C. Greene, MD, who directs virology and immunology research at the Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
SAN FRANCISCO—July 15, 2012—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr.
Awards Alzheimer’s Disease Mucke Lab
SAN FRANCISCO, CA—July 5, 2012—Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell—called an iPS cell—that is derived from adult skin cells.
Stem Cells/iPSCs
SAN FRANCISCO, CA—June 28, 2012—Scientists at the Gladstone Institutes and an international team of researchers have generated a human model of Huntington's disease—directly from the skin cells of patients with the disease.
Huntington’s Disease
